Original language | English (US) |
---|---|
Pages (from-to) | 1976-1978 |
Number of pages | 3 |
Journal | Lancet |
Volume | 369 |
Issue number | 9578 |
DOIs |
|
State | Published - Jun 16 2007 |
All Science Journal Classification (ASJC) codes
- General Medicine
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Lancet, Vol. 369, No. 9578, 16.06.2007, p. 1976-1978.
Research output: Contribution to journal › Comment/debate › peer-review
TY - JOUR
T1 - Snus-what should the public-health response be?
AU - Foulds, Jonathan
AU - Kozlowski, Lynn
N1 - Funding Information: JF is mainly funded by the New Jersey Department of Health and Senior Services. His other current research funding is from the Cancer Institute of New Jersey, and the Robert Wood Johnson Foundation. He is also a co-investigator on grants from the National Institutes of Health (NIH). He has worked as a consultant and received honoraria from drug companies involved in production of tobacco-dependence treatments, and agencies involved in promoting health (eg, WHO, NIH). Several of these agencies provide sponsorship funds for educational events by the programme he directs. This programme (Tobacco Dependence Program at UMDNJ-School of Public Health) does training and charges health professionals and their organisations. He has worked as an expert witness in litigation, including for plaintiffs against tobacco companies. He has not received any funding from the tobacco industry other than deposition fees from defendants' attorneys in litigation against the tobacco industry (while acting as a witness for plaintiffs). He is compensated for writing a regular column on a health website ( http://www.healthline.com/blogs/smoking_cessation ). LK receives research funding from the US National Cancer Institute, and has been funded by the Robert Wood Johnson Foundation. He receives no funding from the tobacco industry. He has worked as a consultant and received honoraria from drug companies involved in production of tobacco-dependence treatments, and agencies involved in promoting health (eg, Robert Wood Johnson Foundation, NIH). He has worked as a paid expert witness in litigation for plaintiffs against tobacco companies.
PY - 2007/6/16
Y1 - 2007/6/16
UR - http://www.scopus.com/inward/record.url?scp=34250196869&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34250196869&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(07)60679-5
DO - 10.1016/S0140-6736(07)60679-5
M3 - Comment/debate
C2 - 17498796
AN - SCOPUS:34250196869
SN - 0140-6736
VL - 369
SP - 1976
EP - 1978
JO - Lancet
JF - Lancet
IS - 9578
ER -